Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Sermadiras

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|December 11, 2013
Recombinant expression and in vitro characterisation of active Huwentoxin-IVIsabelle Sermadiras, Jefferson Revell, John E Linley, et al.
Mabs|September 26, 2025
Accelerating antibody development: sequence and structure-based models for predicting developability properties via size exclusion chromatographyA N M Nafiz Abeer, Mehdi Boroumand, Isabelle Sermadiras, et al.
The Biochemical Journal|July 17, 2016
Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonistsJacqueline Naylor, Arthur T Suckow, Asha Seth, et al.
Cardiovascular Research|March 4, 2025
A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunctionMonika Papworth, Spoorthy Kulkarni, Madeleine Antonsson, et al.
Molecular Cancer|December 16, 2011
Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicityHang Fai Kwok, Richard J Buick, Diana Kuehn, et al.
Molecular Metabolism|November 15, 2021
Peptide-YY<sub>3-36</sub>/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitriesBrandon B Boland, Rhianna C Laker, Siobhan O'Brien, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|December 11, 2013
Recombinant expression and in vitro characterisation of active Huwentoxin-IVIsabelle Sermadiras, Jefferson Revell, John E Linley, et al.
Mabs|September 26, 2025
Accelerating antibody development: sequence and structure-based models for predicting developability properties via size exclusion chromatographyA N M Nafiz Abeer, Mehdi Boroumand, Isabelle Sermadiras, et al.
The Biochemical Journal|July 17, 2016
Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonistsJacqueline Naylor, Arthur T Suckow, Asha Seth, et al.
Cardiovascular Research|March 4, 2025
A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunctionMonika Papworth, Spoorthy Kulkarni, Madeleine Antonsson, et al.
Molecular Cancer|December 16, 2011
Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicityHang Fai Kwok, Richard J Buick, Diana Kuehn, et al.
Molecular Metabolism|November 15, 2021
Peptide-YY<sub>3-36</sub>/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitriesBrandon B Boland, Rhianna C Laker, Siobhan O'Brien, et al.
Pageof 1